Innovative teaching profile

• "Basic Research to Product": From molecular basics to drugs

• Clinical trials: Realization of clinical trials by the Clinical Trial Center of the Department of Neurology

• Wide range of elective courses in coordination with individual specialties

• Close cooperation with the pharmaceutical industry partner Boehringer Ingelheim: Lecture series/seminars by experts from Boehringer Ingelheim CNS Diseases Research

• Interdisciplinary education in an international environment

Practice-based teaching

Training in the modern laboratories of Ulm University and the University Hospital Ulm with the focus on:

• Amyothrophic lateral sclerosis

• Motor system diseases

• Dementia / Alzheimer

• Epilepsy

• Huntington's disease

• Multiple Sclerosis

• Inflammatory CNS diseases

• Parkinson's syndromes

• Movement disorders

• Stroke diseases

High practical part through internships of several weeks in external laboratories and clinics as well as in the industry (national and international)

Practical training in product development

Excellent supervision

• Small, manageable student groups (max. 20 students) and personal contact with lecturers and experts from industry

• Mentoring program for students with prior education outside the laboratory

• Direct contact to scientists and contact persons in academia, industry and business

The program comprises four semesters of standard study time and concludes with the Master of Science degree. In the case of a Master's thesis in the laboratory, the study time can also be extended to five semesters (2.5 years).

The study plan provides information on the structure of the course. There are compulsory and elective modules. You must achieve a minimum of 120 credit points (ECTS) to graduate. You can acquire 30 credit points in each semester.

Studyplan   Curriculum

At the beginning of the program, introductory basic courses teach the cellular and molecular processes in the nervous system that can lead to disease. The theoretical, methodological and practical basic knowledge is then applied to potential new diagnostic and therapeutic procedures and clinical applications. The focus is on understanding and researching molecular mechanisms and neurological and psychiatric diseases with the aim of improving diagnostics and developing drugs and therapeutic procedures against the diseases, in addition to basic research.

The pharmaceutical industry partner Boehringer Ingelheim is closely associated with the program and shows the way from basic research to therapeutics developments.
The syllabus is taught in lectures and seminars, but students also complete at least two 1-week and three 4-week laboratory internships. These, as well as the 6-month master's thesis, can be completed in preclinical, clinical and biological institutes at the University of Ulm, at the University Hospital Ulm, at external institutes and research facilities in Germany and abroad, as well as at Boehringer Ingelheim.